This special collection entitled “Working hard or hardly working? The latest research on exercise and prostate cancer” features articles published in Prostate Cancer and Prostatic Diseases (PCAN) in ...
Discovered: There is such a thing as too much exercise, a new Prostate cancer drug, American heads are getting bigger, bug bombs don't work on bed bugs and a mysterious radioactive event.
February 1, 2012 — A new study suggests that vigorous physical activity will offer protection against prostate cancer progression because of its effects on DNA repair and cell-cycle pathways. The ...
Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to ...
Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to ...
Credit: Thinkstock Investigators report beneficial effects of aerobic high-intensity training on cardiometabolic biomarkers. Men on active surveillance for prostate cancer who participated in aerobic ...
Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...
Men with prostate cancer who participated in group-based resistance and aerobic exercise regimens had improved sexual function compared with those who underwent usual care. Men with prostate cancer ...
Please provide your email address to receive an email when new articles are posted on . Exercise 3 days per week improved sexual function for men with prostate cancer vs. usual care. Exercise also ...
Most men experience sexual issues, including erectile dysfunction, after prostate cancer treatment. Regular cardiovascular and strength training workouts can significantly improve sexual function, ...
Mechanism of action (MOA) for TGF-ß2 driven survival. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global Summit for Oncology Innovators. This abstract does not include a full text ...